Management & Regulatory

Can Europe's Medical Gloves Market Overcome Environmental Challenges?
Management & Regulatory Can Europe's Medical Gloves Market Overcome Environmental Challenges?

The Europe medical gloves market, valued at USD 4.35 billion in 2024, is set to grow steadily, reaching USD 7.89 billion by 2033. As healthcare demands rise, so does the reliance on medical gloves—a critical component in infection control. However, environmental concerns loom large over this b

Home-Based Primary Care Bringing Vital Services to Rural Veterans
Management & Regulatory Home-Based Primary Care Bringing Vital Services to Rural Veterans

Picture a scenario where a Veteran living in a remote part of West Texas struggles to get to the nearest healthcare facility due to the long distances, lack of transportation, and a hefty list of chronic health conditions. This Veteran is part of a growing number of aging and homebound individuals

MyMichigan Medical Center Sault Named Top 100 Rural Hospital for 2025
Management & Regulatory MyMichigan Medical Center Sault Named Top 100 Rural Hospital for 2025

MyMichigan Medical Center Sault has been recognized by The Chartis Center for Rural Health as one of the 2025 Top 100 Rural & Community Hospitals in the United States. This accolade highlights the hospital's exceptional performance in providing top-notch healthcare to rural communities and

Are New Zealand's Health Data Protection Measures Sufficient Enough?
Management & Regulatory Are New Zealand's Health Data Protection Measures Sufficient Enough?

When a routine investigation by New Zealand authorities revealed alarming gaps in the protocols for managing health data, the country found itself grappling with an urgent and complex challenge. In an era where data breaches are becoming increasingly frequent and sophisticated, the protection of

Will Henlius Biotech Thrive After Fosun Pharma's Failed Buyout Attempt?
Management & Regulatory Will Henlius Biotech Thrive After Fosun Pharma's Failed Buyout Attempt?

Fosun Pharmaceutical, a leading Chinese pharmaceutical conglomerate, recently attempted to take full control of its biopharma subsidiary, Henlius Biotech, by purchasing the remaining minority shares. This strategic move aimed to consolidate Henlius under Fosun's complete ownership, leveraging

CDMO Sector Faces Challenges and Opportunities Amid 2024 Market Shifts
Management & Regulatory CDMO Sector Faces Challenges and Opportunities Amid 2024 Market Shifts

The Contract Development and Manufacturing Organization (CDMO) sector is navigating a landscape marked by significant changes and evolving trends. Gil Roth, President of the Pharma & Biopharma Outsourcing Association, provides a comprehensive analysis of the sector's current state and

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later